4.5 Article

Hepatitis A and travel amongst Nova Scotia postsecondary students: Evidence for a targeted vs. universal immunization strategy

Journal

VACCINE
Volume 28, Issue 51, Pages 8105-8111

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2010.09.107

Keywords

Hepatitis A vaccine; Universal immunization; Travel

Funding

  1. Dalhousie Medical Research Foundation/Faculty of Medicine
  2. CIHR
  3. IWK Health Centre

Ask authors/readers for more resources

Background: Canadian guidelines recommend hepatitis A virus (HAV) vaccination for high-risk persons, such as travelers to HAV-endemic areas. The US CDC advocates universal immunization. Objectives: To explore whether a universal strategy for HAV immunization rather than the Canadian targeted approach for travelers is justified by measuring compliance of postsecondary students with Canadian guidelines. Methods: A cross-sectional study using an electronic survey method elicited HAV risk factors, immunization history, disease status, and factors affecting immunization status from postsecondary students. Seropositivity was determined by measuring HAV antibodies in saliva from a convenience sample of survey participants within each study group. Statistical analysis used Fisher's exact test and logistic regression. Results: We received 2279 completed surveys (10.6% response) and 235 saliva samples (58.7% response). A total of 1380 (60.6%) participants had traveled to HAV-endemic regions and 1851(81.2%) were planning to do so within the next 5 years. Less than half who traveled to HAV-endemic areas reported a history of HAV vaccination (48.0%). HAV seropositivity rates were higher amongst those who traveled to (63.6%) or were planning to travel to (55.0%) HAV-endemic areas than those who had never traveled or had no plans to travel to such areas (17.4%). Only 8.9% of unvaccinated students were seropositive (5.3% of Canadianborn students). Amongst unvaccinated, seropositive students, there was a nonsignificant trend for higher seropositivity in those who had previously traveled to HAV-endemic areas (14.7%) than those who had not traveled abroad (4.4%), suggesting an exposure to HAV during travel. Nearly all (96.5%) unvaccinated students, who were willing to be vaccinated based on current knowledge or if their doctor recommended it, indicated a willingness to receive vaccine if it were provided free of charge. Conclusions: Current Canadian guidelines for HAV vaccination are not being followed within the postsecondary student population. Given high rates of travel to HAV-endemic areas in this population, a universal approach to HAV vaccination may be warranted. (c) 2010 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pediatrics

The palivizumab patchwork: Variation in guidelines for Respiratory Syncytial Virus prevention across Canadian provinces and territories

Matthew Jalink, Joanne M. Langley

Summary: There is substantial variation in qualifications for RSV prevention with palivizumab among Canadian provinces and territories, and none of them strictly adhere to the guidelines set by the Canadian Paediatric Society. The differences in subnational policies may be due to factors such as resource availability, interpretation of efficacy evidence, epidemiological variations, local pressures, or advocacy efforts.

PAEDIATRICS & CHILD HEALTH (2021)

Review Immunology

Influenza vaccination and the evolution of evidence-based recommendations for older adults: A Canadian perspective

Melissa K. Andrew, Shelly A. McNeil

Summary: In Canada, public health efforts for influenza prevention are multi-pronged and include vaccination programs and surveillance. Recommendations are made nationally by NACI, but vaccination programs vary by province/territory.

VACCINE (2021)

Article Geriatrics & Gerontology

Recombinant Zoster Vaccine Is Efficacious and Safe in Frail Individuals

Desmond Curran, Joon H. Kim, Sean Matthews, Christophe Dessart, Myron J. Levin, Lidia Oostvogels, Megan E. Riley, Kenneth E. Schmader, Anthony L. Cunningham, Shelly A. McNeil, Anne E. Schuind, Melissa K. Andrew

Summary: Frail participants, including frail older adults, had a high efficacy of recombinant zoster vaccine against herpes zoster, with a reduced risk of adverse events as frailty increased.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2021)

Article Geriatrics & Gerontology

Persistent Functional Decline Following Hospitalization with Influenza or Acute Respiratory Illness

Melissa K. Andrew, Sarah MacDonald, Judith Godin, Janet E. McElhaney, Jason LeBlanc, Todd F. Hatchette, William Bowie, Kevin Katz, Allison McGeer, Makeda Semret, Shelly A. McNeil

Summary: This study investigated the persistent functional change in older adults admitted to hospital with influenza and other acute respiratory illness (ARI). It found that higher baseline frailty was associated with increased odds of experiencing functional decline, catastrophic disability, and death, with similar risks observed for influenza and other ARI admissions.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2021)

Article Immunology

An early look at the second dose completion of the recombinant zoster vaccine in Canadian adults: A retrospective database study

Ashleigh McGirr, Tara Bourgoin, Michael Wortzman, Brad Millson, Shelly A. McNeil

Summary: This study evaluated the second-dose completion of RZV in Canada, finding high but suboptimal completion rates, indicating the need for further research to understand the factors influencing second dose timing and completion in order to improve series completion.

VACCINE (2021)

Article Public, Environmental & Occupational Health

Mechanical complications of central venous catheters in children: A cohort study

Kieran J. Moore, David Greencorn, Nadine Smith, Joanne M. Langley, Ketan Kulkarni

Summary: This study found that mechanical complications of CVCs are common and significant in the pediatric population, with the highest risk seen in non-tunneled lines. The authors suggest that CVC-associated mechanical complications should be routinely reported as a patient safety outcome.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2022)

Article Immunology

The half-life of maternal transplacental antibodies against diphtheria, tetanus, and pertussis in infants: an individual participant data meta-analysis

Blanche Oguti, Asad Ali, Nick Andrews, Daan Barug, Duc Anh Dang, Scott A. Halperin, Ha Thi Thu Hoang, Beth Holder, Beate Kampmann, Abdul M. Kazi, Joanne M. Langley, Elke Leuridan, Naomi Madavan, Kirsten Maertens, Herberth Maldonado, Elizabeth Miller, Flor M. Munoz-Rivas, Saad B. Omer, Andrew J. Pollard, Thomas F. Rice, Nynke Rots, Maria E. Sundaram, Nasamon Wanlapakorn, Merryn Voysey

Summary: This study aimed to calculate the half-lives of passively acquired diphtheria, tetanus, and pertussis antibodies in infants. The decay rates of maternal antibodies were found to vary for different antigens but were not significantly influenced by demographic or vaccine characteristics.

VACCINE (2022)

Article Biotechnology & Applied Microbiology

Exploring the impact of media and information on self-reported intentions to vaccinate against COVID-19: A qualitative interview-based study

Jeanna Parsons Leigh, Donna Halperin, Sara J. Mizen, Emily A. FitzGerald, Stephana Julia Moss, Kirsten M. Fiest, Antonia Di Castri, Henry T. Stelfox, Scott Halperin

Summary: This study explored the influence of media and information on individuals' intentions to vaccinate against COVID-19 and found that while many people intended to vaccinate, concerns and hesitancy still exist. Confidence, complacency, and convenience are key factors influencing vaccination intentions.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)

Article Pediatrics

Infected branchial cleft cyst in a newborn

Jennifer B. Frazer, Dafydd A. Davies, Joanne M. Langley

Summary: This report presents a case of a newborn with a Staphylococcus aureus infection of a branchial cleft anomaly (BCA) and reviews the characteristics and frequency of infection of this congenital anomaly over 18 years at our center. It is found that 6% of patients presented as neonates and 42% of BCAs became infected.

JOURNAL OF PEDIATRIC SURGERY CASE REPORTS (2022)

Article Biotechnology & Applied Microbiology

Vaccine regulation should require and enforce the inclusion of pregnant and breastfeeding women in prelicensure clinical trials

Terra A. Manca, Manish Sadarangani, Scott A. Halperin, Joanne M. Langley, Elisabeth McClymont, Shannon E. MacDonald, Karina A. Top

Summary: Exclusion of pregnant and breastfeeding women from COVID-19 vaccine trials has led to knowledge gaps, vaccine hesitancy, and misinformation. Inclusion of these populations in trials should be prioritized and regulatory authorities can play a crucial role.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)

Article Biotechnology & Applied Microbiology

Kawasaki disease following immunization reported to the Canadian Immunization Monitoring Program ACTive (IMPACT) from 2013 to 2018

Khaled Alsager, Nirma Khatri Vadlamudi, Taj Jadavji, Julie A. Bettinger, Cora Constantinescu, Wendry Vaudry, Ben Tan, Laura Sauve, Manish Sadarangani, Scott A. Halperin, Karina A. Top

Summary: This study characterized Kawasaki disease cases reported to the Canadian Immunization Monitoring Program ACTive (IMPACT) between 2013 and 2018. Cases primarily occurred within 0-42 days following vaccination and showed temporal association with diphtheria-tetanus acellular pertussis and pneumococcal conjugate vaccines. Echocardiogram results indicated abnormality in about half of the cases.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)

Article Public, Environmental & Occupational Health

Risk factors for mechanical complications of peripherally inserted central catheters in children

David J. Greencorn, Stefan Kuhle, Lingyun Ye, Kieran J. Moore, Ketan P. Kulkarni, Joanne M. Langley

Summary: Risk factors for mechanical complications in children with PICCs have been identified, which can improve best practices for PICC insertion and care.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2023)

Article Immunology

Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus Vaccine (RSVPreF3) in Mothers and Their Infants: A Phase 2 Randomized Trial

Zourab Bebia, Osvaldo Reyes, Robert Jeanfreau, Anu Kantele, Ruth Graciela De Leon, Marta Garcia Sanchez, Peyman Banooni, Glenn J. Gardener, Jose Luis Bartha Rasero, Maria Begona Encinas Pardilla, Joanne M. Langley, Claudio Maanon Di Leo, Elisabeth Botelho-Nevers, Jim Buttery, Helene Laurichesse, Shabir A. Madhi, Adrian Martin Garcia, Thorsten Stanley, Tiphaine Barjat, Rebecca Griffith, Maria Mercedes Castrejon-Alba, Magali de Heusch, Ilse Dieussaert, Melanie Hercor, Patricia Lese, Hui Qian, Antonella N. Tullio, Ouzama Henry

Summary: Maternal vaccination with RSVPreF3 during late pregnancy has an acceptable safety risk profile and induces robust RSV-specific immune responses with successful antibody transfer to newborns.

JOURNAL OF INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Evaluation of Clinical Case Definitions for Respiratory Syncytial Virus Lower Respiratory Tract Infection in Young Children

Janet A. Englund, Rachel A. Cohen, Veronique Bianco, Joseph B. Domachowske, Joanne M. Langley, Shabir A. Madhi, Khalequ Zaman, Agustin Bueso, Ana Ceballos, Luis Cousin, Sanjay Gandhi, Olivier Gruselle, Lisa Jose, Nicola P. Klein, Anthonet Koen, Thanyawee Puthanakit, Meng Shi, Peter Silas, Auchara Tangsathapornpong, Jamaree Teeratakulpisarn, Timo Vesikari, Gerco Haars, Amanda Leach, Sonia K. Stoszek, Ilse Dieussaert

Summary: Respiratory syncytial virus (RSV) causes respiratory illnesses ranging from common cold to moderate and severe lung disease. Symptoms and methods used to identify/track RSV disease are not always the same in different settings. Three definitions of RSV disease were compared with the World Health Organization (WHO) recommendation in 2015. A universal definition of RSV disease and severity is needed for effective treatment and prevention measures.

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2023)

No Data Available